Back

Inhibiting doxorubicin-induced cardiotoxicity by endothelial protection.

29 April 2017 (17:15 - 17:30)
Organised by:
Congress Presentation Part of: Cancer and the heart Cancer/Cardiotoxicity HFA Premium Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

About the speaker

Photo
Professor Kari Alitalo

Wihuri Research Institute, Helsinki (Finland)

3 More presentations in this session

Presentation thumbnail
Clinical perspective.
Doctor A. Lyon (London, GB)
Slides Video
Presentation thumbnail
Metabolic aspects.
Doctor H. Taegtmeyer (Houston, US)
Slides Video
Presentation thumbnail
Obesity and chemotherapy toxicity.
Professor C. Vergely (Dijon, FR)
Slides Video

Access the full session

Session thumbnail
Cancer and the heart

The Event

Event poster

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April 2017 17:15 CET
You may be interested in
thumbnail
Congress Presentation
Anthracycline-induced cardiotoxicity: the role of endothelial dysfunction
29 June 2021
thumbnail
Congress Session
Young Investigator Award (YIA) Basic Science
17 May 2025
thumbnail
Congress Presentation
Cardioprotective effects of the flavonoid quercetin against doxorubicin-Induced cardiotoxicity in H9c2 cardiomyoblasts
20 June 2025
thumbnail
Congress Presentation
Administration of doxorubicin increases the sensitivity of the mitochondrial permeability transition pore to calcium and causes pathological changes in the electrocardiography.
21 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources